By Steve Buxser, Ph.D., Nerac Analyst,
Originally Published: November 6, 2015
We face the distinct possibility of not being able to treat an increasing number of bacterial infections that for more than 50 years were routinely and highly effectively treated nearly immediately upon diagnosis. In fact, often they were not really diagnosed, which turned out to be a significant part of the problem since it led to excessive use of antibiotics. No more. While the large majority of infections are still treated effectively with existing antibiotics, it is certainly now clear that such effective treatment is already diminishing and will continue to deteriorate, unless critical steps are taken.
This report looks into the issue of antibiotic resistance and the development of new antimocrobials.
Want to read the rest of the article? Fill out the form to download: Antibiotic Resistant Bacteria - Threats and Opportunities
